CONJUGATE OF NANOPARTICLES OF GOLD-MAGNETITE COMPOSITION WITH FUNCTIONAL MOLECULE (OPTIONS) AND METHOD OF USE (OPTIONS) Russian patent published in 2024 - IPC C07F19/00 A61K47/50 A61K49/00 G01N33/53 B82B1/00 B82Y5/00 B82Y40/00 C07F1/12 C07F15/02 

Abstract RU 2811020 C1

FIELD: biomedicine and nanomedicine.

SUBSTANCE: invention relates to conjugates of a nanoparticle with a functional molecule for medical use, characterized by the following: on the surface of a water-compatible stable nanoparticle with magnetic properties consisting of gold and magnetite Fe3O4, a stabilizing compound with a carboxyl group is immobilized, which is a carbene ligand of formula (I), where R1 and R2 are independently selected from the group consisting of COOR5 or COOR6; R3 and R4 are independently selected from the group consisting of H, C1-C6 alkyl, C3-C7 cycloalkyl, C1-C6 alkyloxy and halogen; R5 and R6 are independently selected from the group consisting of H; C1-C6 alkyl; C3-C7 cycloalkyl; C1-C6 alkyloxy and halogen. The proposed conjugate retains colloidal stability after drying and has the ability to resuspend in water, in a buffer aqueous solution or in a biological sample. Nanoparticle sizes range from 5 to 100 nm. The specified nanoparticle is connected to the functional molecule directly or using a linker having the general formula СONH(CH2)m Y, where Y=COOH, NH2, SH, CONH2, OH, CHO, CO-PEG-OH or CO- PEI-NH2, m can take values from 3 to 12, the functional molecule is selected from the group consisting of a therapeutic drug or a diagnostic substance. In particular, the functional group may be a small molecule, coumarin, photosensitizer, protein, carbohydrate, lipid, DNA, transporter, template, ribosomal or microRNA, synthetic nucleic acid analogs, synthetic polymer polyethylene glycol or polyethyleneimine, a pharmacologically active compound. The invention also relates to a method of using the specified conjugate in magnetic resonance imaging, spectrophotometric analysis, enzyme-linked immunosorbent assay, immunochromatographic analysis, as a contrast for computed tomography, for detection of target molecules, for delivery of target molecules into living cells and organisms, as an agent for radiotherapy, for targeted delivery of a therapeutic drug into cells.

EFFECT: increase of the colloidal stability of conjugates of magnetite-gold nanoparticles (Fe3O4@AuNP@NHC) with functional molecules to external physical and chemical exposure, including in biological environments, as well as facilitating the process of storage and transportation due to the ability of these conjugates to maintain colloidal stability upon drying, ensuring the possibility of delivering diagnostic and medicinal substances to target cells.

77 cl, 10 dwg, 29 ex

Similar patents RU2811020C1

Title Year Author Number
NANOPARTICLE OF GOLD-MAGNETITE COMPOSITION, METHOD OF PRODUCING NANOPARTICLE (VERSIONS), CONJUGATE BASED ON IT (VERSIONS), METHOD OF PRODUCING CONJUGATE AND TEST KIT 2023
  • Ivantsova Polina Mikhajlovna
  • Kolychev Evgenij Leonidovich
  • Mochalova Elizaveta Nikitichna
  • Sizikov Artem Aleksandrovich
  • Nikitin Maksim Petrovich
RU2814660C1
NANOAGENTS FOR SCREENING PATHOGENIC STRAINS OF MULTIDRUG-RESISTANT BACTERIA AND METHOD OF PREPARATION 2022
  • Nikitin Maksim Petrovich
  • Ryngach Alina
RU2804488C1
METHOD OF DETECTING PATHOGENIC BACTERIA STRAINS 2022
  • Nikitin Maksim Petrovich
  • Ryngach Alina
RU2802435C1
CARBENE LIGAND AND ULTRASTABLE GOLD NANOPARTICLES ON ITS BASIS 2021
  • Kolychev Evgenij Leonidovich
  • Ivantsova Polina Mikhajlovna
  • Mochalova Elizaveta Nikitichna
  • Nikitin Maksim Petrovich
RU2792581C1
DOXORUBICIN-GOLD NANOCONJUGATES WITH DIRECTIONAL INFLUENCE FOR TUMOR THERAPY 2018
  • Kannan, Raghuraman
  • Zambre, Ajit
  • Upendran, Anandhi
RU2773707C2
IONISABLE CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY 2023
  • Boldyrev Ivan Aleksandrovich
  • Shendrikov Valerij Pavlovich
  • Kislova Svetlana Olegovna
  • Andreev Dmitrij Evgenevich
  • Poteshnova Mariya Viktorovna
  • Rubtsova Mariya Petrovna
  • Rubtsov Yurij Petrovich
  • Vodovozova Elena Lvovna
RU2823298C1
RECEPTOR TARGETING CONSTRUCTS AND USES THEREOF 2015
  • Medina-Kauve Lali K.
RU2682335C2
METHOD FOR PREPARING PHARMACEUTICALLY ACCEPTABLE DOSAGE FORMS AND USING THEM IN COMBINED CHEMOTHERAPY AND PHOTODYNAMIC THERAPY OF MALIGNANT NEOPLASMS 2023
  • Akhmetova Daria Ramilevna
  • Timin Aleksandr Sergeevich
  • Iakubova Anastasiia Arturovna
  • Aiia Darvish Akhmed Morsi
  • Muslimov Albert Radikovich
RU2822629C1
MEDICINAL PRODUCT FOR TREATMENT OF BREAST CANCER 2017
  • Abakumov Maksim Artemovich
  • Semkina Alevtina Sergeevna
  • Chekhonin Vladimir Pavlovich
RU2657545C1
NEW OLIGONUCLEOTIDES CONJUGATES AND USE THEREOF 2012
  • Chkhe Chejuk
  • Khan Boram
  • Kim Khan-Na
  • Pak Khan O
  • Yun Pen O
  • Kim Sun Gi
  • Chon Kvan-Chu
  • Kvon Tkheu
  • Chkhve Chon Dok
  • Li Sam Yun
  • Chon Yn-Chun
RU2599449C1

RU 2 811 020 C1

Authors

Nikitin Maksim Petrovich

Mochalova Elizaveta Nikitichna

Sizikov Artem Aleksandrovich

Kolychev Evgenii Leonidovich

Ivantsova Polina Mikhailovna

Dates

2024-01-10Published

2023-04-10Filed